Inato
We're Hiring!
Inato Company Growth, Stability & Outlook
What People Are Saying About Inato
-
Market Expansion: Public materials highlight growth from roughly 2,500+ to 5,500–6,000+ research sites across 50+ countries and an increase to 25+ sponsors on the platform. Feedback suggests the marketplace is scaling on both the supply (sites) and demand (sponsors) sides.
-
Strategic Partnerships: Named collaborations with AbbVie, Sanofi, and Moderna, plus integrations with RealTime‑Devana and CRIO, demonstrate blue‑chip adoption and expanding ecosystem reach. Feedback suggests repeated use on consequential trials and data‑sharing ties are strengthening commercial durability.
-
Innovation-Driven Growth: Recent launches such as AI Site Selection and AI patient pre‑screening target bottlenecks in planning, site selection, and enrollment. External recognition (e.g., Fast Company’s Most Innovative Companies with adoption more than doubling in 2023) signals momentum behind product innovation.
